Intraocular silicone prosthesis implantation in eyes of dogs and a cat with intraocular neoplasia: nine cases (1983-1994)
McLaughlin, S.A.; Ramsey, D.T.; Lindley, D.M.; Gilger, B.C.; Gerding, P.A.; Whitley, R.D.
Journal of the American Veterinary Medical Association 207(11): 1441-1443
1995
ISSN/ISBN: 0003-1488 PMID: 7493872 Document Number: 454849
Intraocular silicone prosthesis (ISP) was implanted in the eyes of 8 dogs and 1 cat with intraocular neoplasia (glaucoma, uveitis, hyphaema and intraocular mass) as an alternative to enucleation. Primary intraocular neoplasms were found in 5 dog and the cat after ISP implantation. The cat developed signs compatible with systemic metastasis 4 years after surgery and was killed. 2 of the dogs developed regrowth of the neoplasm around the IPS 6 to 24 months after implantation, and the eyes were enucleated. 3 dogs had multicentric or metastatic neoplasia involving the eye. 2 of these were killed because of their systemic disease 1.5 to 7 months after ISP implantation. The third dog is alive without evidence of regrowth 3 years after surgery. It is concluded that intraocular neoplasia is not an absolute contraindication to IPS implantation.